About Bennu Bioscience
Bennu Bioscience is a company based in Delhi (India) founded in 2018. It operates as a B2B. Bennu Bioscience operates in a competitive market with competitors including Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
- Headquarter Delhi, India
- SectorsHealthcare
- Email••••••••
- Website bennubioscience.com
- Legal Name Bennu Bioscience Private Limited
- Date of Incorporation 25 Sep, 2018
- Jurisdiction Delhi, India
- Annual Revenue₹9.03 Cr
FY 2024 · +3294% YoY
- Net Loss-₹0.36 Cr
FY 2024 · -4% margin
- EBITDA-₹0.30 Cr
FY 2024 · -3% margin
Associated legal entities of Bennu Bioscience
Bennu Bioscience operates through Bennu Bioscience Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bennu Bioscience Private Limited CIN U51909DL2018PTC339398 | Active | 25 Sep 2018 | Delhi, Delhi | ₹9.0 Cr | – | 3 | View details |
Board of directors of Bennu Bioscience Private Limited (Bennu Bioscience)
Bennu Bioscience Private Limited is the primary company behind Bennu Bioscience. The board of Bennu Bioscience Private Limited currently have 3 directors; the longest-serving is Yu Zhang, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Yu Zhang DIN 06429660 | Director | 25 Sep 2018 | 8 yrs | Bennu Bioscience Private Limited |
| Weini Pa DIN 08212310 | Director | 25 Sep 2018 | 8 yrs | Bennu Bioscience Private Limited |
| Rajeev Kumar Pathak DIN 08543126 | Additional Director | 15 May 2021 | 5 yrs 4 mo | Bennu Bioscience Private Limited |
Financials of Bennu Bioscience
Figures of Bennu Bioscience Private Limited, the primary company behind Bennu Bioscience, for FY 2024. Revenue was ₹9.03 Cr (+3294% year on year). Net loss was -₹0.36 Cr (-4% margin). EBITDA was -₹0.30 Cr (-3% margin). Revenue has grown at a compounded annual rate of +1% over three years and +128% over five years.
- ₹9.03 CrRevenue · FY 2024 · +3294% YoY
- -₹0.36 CrNet loss · -4% margin
- -₹0.30 CrEBITDA · -3% margin
- ₹0.01 CrPaid-up capital
- +1%Revenue CAGR, 3 years
- +128%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bennu Bioscience Private Limited are on its company page.
Detailed financial statements for Bennu Bioscience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Bennu Bioscience
Bennu Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neovacs.com | 1993 | Paris, France | $17.91M | – | Vaccine manufacturing services are provided by Neovacs CDMO. | |
| intravacc.nl | 2012 | Bilthoven, Netherlands | – | – | Vaccine development services for bacterial and viral vaccines are provided. | |
| finabio.net | 2006 | Rockville, United States | $3M | – | Biotechnology company specializing in bioconjugation services mainly for vaccine development | |
| yapanbio.com | 2019 | Hyderabad, India | $13.4M | 69 | Contract manufacturing of bio-therapeutics and vaccines is provided. | |
| veraxa.com | 2017 | Heidelberg, Germany | $3.41M | – | Antibody therapeutics for cancer treatment are developed via microfluidic screening. | |
| primrosebio.com | 2023 | San Diego, United States | $15M | – | New molecules are discovered, developed, and manufactured in biotechnology. | |
| westvacpharma.com | 2021 | Lanzhou, China | – | – | COVID-19 vaccines are manufactured via CDMO services by WestVac Biopharma. | |
| gcbiopharma.com | 1967 | – | – | – | Functions as a CDMO focused on manufacturing vaccines. |
Detailed competitors of Bennu Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Bennu Bioscience
10 companies that operate in the same segment as Bennu Bioscience (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bennu Bioscience
Bennu Bioscience was founded in 2018.
Bennu Bioscience is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Bennu Bioscience, Bennu Bioscience Private Limited, reported revenue of ₹9.03 Cr for FY 2024, up 3294% year on year.
Bennu Bioscience, based in Delhi, focuses on providing healthcare solutions, advancing biotech innovations, vaccine manufacturing, and cdmo services. A CDMO specializing in vaccine manufacturing for pharmaceutical needs. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Bennu Bioscience operates through Bennu Bioscience Private Limited.
The legal entities of Bennu Bioscience currently have 3 directors, including Rajeev Kumar Pathak, Yu Zhang, Weini Pa.